Home/Cabaletta Bio/Gwendolyn Binder, Ph.D.

GB

Gwendolyn Binder, Ph.D.

President, Science & Technology

Therapeutic Areas

Autoimmune Diseases Rheumatology Dermatology Neurology

Cabaletta Bio Pipeline

Drug	Indication	Phase
rese-cel (resecabtagene autoleucel)	Systemic Lupus Erythematosus (SLE)	Phase 1/2

Leadership Team at Cabaletta Bio

Steven Nichtberger, M.D.

President, Chief Executive Officer, and Co-Founder

Samik Basu, M.D.

Chief Scientific Officer

Catherine Bollard, M.D.

Independent Director

View full Cabaletta Bio profile